NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
1.65
Dollar change
-0.02
Percentage change
-1.20
%
Index- P/E- EPS (ttm)-0.57 Insider Own0.54% Shs Outstand37.39M Perf Week-4.07%
Market Cap61.69M Forward P/E- EPS next Y-0.60 Insider Trans0.00% Shs Float37.19M Perf Month-7.82%
Enterprise Value46.84M PEG- EPS next Q-0.18 Inst Own41.23% Short Float0.17% Perf Quarter-23.26%
Income-21.25M P/S0.92 EPS this Y-18.61% Inst Trans-0.38% Short Ratio0.76 Perf Half Y-24.66%
Sales67.04M P/B1.66 EPS next Y16.17% ROA-22.13% Short Interest0.06M Perf YTD-25.34%
Book/sh1.00 P/C2.50 EPS next 5Y12.56% ROE-35.41% 52W High5.46 -69.78% Perf Year-68.09%
Cash/sh0.66 P/FCF- EPS past 3/5Y- - ROIC-51.98% 52W Low1.26 30.95% Perf 3Y-75.91%
Dividend Est.- EV/EBITDA- Sales past 3/5Y10.02% 6.65% Gross Margin40.33% Volatility6.48% 5.53% Perf 5Y-39.67%
Dividend TTM- EV/Sales0.70 EPS Y/Y TTM-14.21% Oper. Margin-32.26% ATR (14)0.12 Perf 10Y-52.59%
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM11.26% Profit Margin-31.70% RSI (14)38.49 Recom2.33
Dividend Gr. 3/5Y- - Current Ratio1.74 EPS Q/Q-36.09% SMA20-5.47% Beta-0.00 Target Price5.84
Payout- Debt/Eq0.26 Sales Q/Q-32.35% SMA50-11.21% Rel Volume0.98 Prev Close1.67
Employees310 LT Debt/Eq0.10 EarningsMay 15 BMO SMA200-27.85% Avg Volume81.52K Price1.65
IPOAug 01, 1997 Option/ShortYes / Yes EPS/Sales Surpr.-29.12% -8.50% Trades Volume80,469 Change-1.20%
Date Action Analyst Rating Change Price Target Change
May-15-25Downgrade Piper Sandler Overweight → Neutral
Apr-04-25Downgrade Jefferies Buy → Hold $2
Nov-01-22Initiated Jefferies Buy $11
Apr-28-21Initiated Piper Sandler Overweight $13
Apr-15-20Initiated B. Riley FBR Buy $5.50
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-20-09Reiterated Roth Capital Hold $2.50 → $5
May-27-25 07:00AM
May-16-25 03:09AM
May-15-25 07:00AM
May-14-25 09:56AM
May-01-25 07:00AM
09:01AM Loading…
Apr-30-25 09:01AM
Apr-29-25 09:05AM
07:00AM
Apr-28-25 01:19PM
Apr-24-25 07:00AM
Apr-22-25 07:00AM
Mar-28-25 03:01AM
Mar-27-25 11:56AM
07:10AM
Mar-06-25 07:00AM
07:00AM Loading…
Mar-03-25 07:00AM
Feb-06-25 08:00AM
Jan-13-25 07:00AM
Jan-10-25 07:00AM
Jan-08-25 07:00AM
Dec-04-24 09:10AM
Dec-02-24 07:00AM
Nov-27-24 07:00AM
Nov-22-24 08:00AM
Nov-19-24 08:00AM
Nov-08-24 06:02AM
Nov-07-24 07:00AM
Nov-06-24 08:00AM
07:50AM
Oct-30-24 01:01AM
08:00AM Loading…
Oct-24-24 08:00AM
Oct-01-24 07:00AM
Sep-19-24 08:00AM
Aug-29-24 08:00AM
Aug-28-24 07:00AM
Aug-07-24 07:00AM
Aug-06-24 07:00AM
Jul-22-24 06:33AM
Jul-19-24 04:15PM
Jul-08-24 07:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-17-24 08:10AM
May-16-24 12:52PM
08:00AM
May-06-24 08:00AM
May-02-24 08:00AM
Apr-23-24 08:00AM
Mar-29-24 09:44AM
Mar-27-24 11:53AM
07:00AM
Mar-13-24 07:00AM
Mar-06-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 07:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 08:00AM
Dec-12-23 08:00AM
Dec-06-23 04:30PM
Nov-30-23 08:00AM
Nov-20-23 08:00AM
Nov-10-23 03:33PM
Nov-09-23 06:00AM
Nov-06-23 08:00AM
Oct-26-23 08:00AM
Sep-06-23 08:00AM
Aug-25-23 09:06AM
Aug-24-23 06:30AM
Aug-10-23 08:00AM
Jul-26-23 08:00AM
Jul-06-23 11:05AM
Jun-09-23 10:37AM
May-24-23 08:00AM
May-17-23 06:30AM
May-05-23 01:33PM
May-03-23 08:00AM
Apr-21-23 08:00AM
Apr-10-23 08:00AM
Apr-06-23 08:00AM
Apr-05-23 07:44PM
Mar-30-23 06:30AM
Mar-24-23 06:30AM
Mar-21-23 04:30PM
Mar-10-23 08:12AM
Mar-09-23 08:00AM
Feb-14-23 09:00AM
Jan-31-23 08:00AM
Jan-21-23 09:29AM
Jan-05-23 08:00AM
Dec-31-22 09:03AM
Dec-23-22 11:43PM
Dec-10-22 08:17AM
Dec-06-22 08:00AM
Nov-30-22 04:01PM
08:50AM
Nov-22-22 08:42AM
Nov-21-22 10:00AM
08:00AM
07:10AM
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANCE WILLSEYDirectorNov 26 '24Proposed Sale2.4730,00074,160Nov 26 04:28 PM
WILLSEY LANCEDirectorNov 25 '24Proposed Sale2.5022,70256,743Nov 25 06:24 PM
LANCE WILLSEYDirectorNov 22 '24Proposed Sale2.5511,38829,068Nov 22 04:43 PM
LANCE WILLSEYDirectorNov 21 '24Proposed Sale2.4810,00024,841Nov 21 04:47 PM
LANCE WILLSEYDirectorNov 20 '24Proposed Sale2.5320,00050,546Nov 20 04:12 PM
LANCE WILLSEYDirectorNov 19 '24Proposed Sale2.4615,01036,925Nov 19 04:52 PM
LANCE WILLSEYDirectorNov 18 '24Proposed Sale2.4720,00049,410Nov 18 04:42 PM
LANCE WILLSEYDirectorNov 15 '24Proposed Sale2.5221,00052,920Nov 15 04:24 PM
LANCE WILLSEYDirectorNov 14 '24Proposed Sale2.5610,00025,620Nov 14 04:54 PM
LANCE WILLSEYDirectorNov 13 '24Proposed Sale2.589,90025,523Nov 13 04:20 PM